What is the survival rate for Myelodysplastic syndrome?

The survival rate for Myelodysplastic Syndromes (MDS) varies widely depending on factors such as the specific subtype of MDS, the patient's age, overall health, and response to treatment. Generally, the median survival ranges from about 20 months to several years, with some patients living much longer, especially those who undergo successful treatment such as stem cell transplantation. Prognostic scoring systems, like the Revised International Prognostic Scoring System (IPSS-R), can help estimate individual survival chances. Regular monitoring and personalized treatment plans are crucial for improving outcomes.